Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Open Access

Amyloidosis and liver. Review.

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPaul CarrierMDMarilyne Debette–GratienJAJulie Abraham

Discussion

Loading...

Member takes

Overview

This review discusses liver involvement in amyloidosis, highlighting diagnosis and treatment options.

Key Points

  • Liver involvement in amyloidosis is observed in 17% to 45% of patients, affecting diagnosis and treatment.
  • Specific criteria for liver disease include elevated alkaline phosphatases and hepatomegaly, indicating involvement.
  • Treatment primarily involves stem cell transplantation and chemotherapy, showing notable advancements in the last decade.
  • Liver involvement recovery is monitored by reductions in alkaline phosphatases and liver size, highlighting treatment effectiveness.

Cite This Study

Carrier et al. (2025) studied this question.

synapsesocial.com/papers/68bb421a2b87ece8dc9587e4https://doi.org/10.37349/edd.2025.100589
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1When AL amyloidosis meets the liver: integrating clinical insight and current understanding2026
  2. 2Liver stiffness in AL amyloidosis: interest in diagnosis and prognosis2026
  3. 3Hepatic amyloidosis in a patient with chronic liver failure: A case report2024 · 1 citations
  4. 4Hepatic multimodal phenotyping in AL amyloidosis with cardiac involvement: the D-Amy-LIPHE study2026
  5. 5A Case of <scp>AL</scp> Amyloidosis With Hepatomegaly as the Main Clinical Manifestation2025